chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: FLUX
Symptoms: Diarrhoea, Fatigue, Nausea, Pain, Vomiting
Clinical narrative: This spontaneous case, reported by other non-health professional (consumer) to VAERS and initially retrieved on 16-Aug-2018 by Seqirus from VAERS (VAERS ID: 723359), concerns a male patient of unspecified age. On an unspecified date, the patient was administered influenza vaccine, (dose, route of administration, anatomical location, batch number, trade name, manufacturer and expiry date: not reported). On unspecified date, after vaccination, the patient experienced gastrointestinal (GI) symptoms: nausea, vomiting and diarrhea. The patient was also fatigue and had body aches. At the time of this report, the outcome of the events was not reported. This case was cross-linked to case 201803391 due to same reporter.
Age: 72.0
Sex: F
Vaccine: FLU3
Symptoms: Axillary mass, Erythema, Induration
Clinical narrative: This spontaneous case, reported by other health professional to the VAERS and initially received on 20-Jun-2018 by Seqirus from the VAERS (VAERS ID: 723823), concerns a 72-year-old, elderly, female patient. The patient's current condition included asthma. The patient was also allergic to morphine. Concomitant medications included: ADVAIR, PROAIR, PREMARIN and Clonazepam for an unknown indication. On 01-Oct-2017, the patient was administered with FLUVIRIN Thiomersal (dose: 0.5 ml (reported as 1 dose), route of administration: injection (reported as SYR), anatomical location: left arm, batch number: 1721201, expiry date: not reported). On 05-Oct-2017, the patient experienced extremely large, red, hard area moving down the arm to the elbow. Additionally, developed a lump under the left armpit. It was reported that, the injection was given low on her deltoid. However, the patient felt that it was not given in the heart of the muscle and wondered if that had something to do with it. The patient made a visit to the physician's office for the events. At the time of this report, the patient had recovered from the events. The reporter assessed the case as non-serious.
Age: 38.0
Sex: M
Vaccine: FLU3, TDAP
Symptoms: Injection site nodule, Injection site pain
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Jun-2018 by Seqirus from VAERS (VAERS ID: 723851), concerns a 38-year-old, adult male patient. The patient had no relevant medical history and current illness. On 23-Oct-2017, the patient was administered with FLUVIRIN (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179803P (explicitly reported as 9XJ5L), expiry date: not reported). On the same day, the patient was also administered with non-company suspect drug BOOSTRIX (route of administration: intramuscular, anatomical location: right arm, batch number: 9XJ5L (explicitly reported as 179803P), dose, expiry date: not reported). On 27-Oct-2017, after 4 days of vaccination, the patient developed golf size knot at the injection site, pain in arm where BOOSTRIX was administered. At the time of this report, the patient had recovered from the events (injection site nodule and injection site pain). The reporter assessed the case as non-serious.
Age: 61.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site swelling, Injection site warmth
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 20-Jun-2018 by Seqirus from VAERS (VAERS ID: 724104), concerns a 61-year-old, adult, female patient. The patient was a smoker. The patient's concomitant medications included atorvastatin and MACROBID for an unknown indication. At the time of vaccination, the patient had no other illness. On 27-Oct-2017, the patient was administered with FLUVIRIN (dose: 0.5 ml [reported as unknown], route of administration: intramuscular, anatomical location: right arm, batch number: 179803P and expiry date: not reported) and PNEUMOVAX (dose: reported as first dose, route of administration: intramuscular, anatomical location: left arm, batch number: N023343 and expiry date: not reported). On 28-Oct-2017, 1 day after vaccination, the patient developed swelling at the site of injection which was warm to touch. The patient tried cold compression and used ALEVE. On the following day, patient reported that, injection site was no longer warm and swelling had decreased. The patient's lab data was reported as negative. On an unspecified date, the patient had recovered from the events. The reporter assessed the events as non-serious.
Age: 49.0
Sex: M
Vaccine: FLU3
Symptoms: Skin exfoliation
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 724291), concerns a 49-year-old, adult male patient. The patient had no relevant medical history, current illness and allergies. The patient did not receive any concomitant medications. On 17-Oct-2017, the patient was administered FLUVIRIN (dose: 0.5 ml, route of administration: intramuscular, anatomical location, batch number, expiry date: not reported). On 21-Oct-2017, 4 days after vaccination, the patient experienced peeling of skin at palm of hands and tip of fingers, which was just like the skin that peels after recovering from the sunburn. At the time of this report, the patient has not recovered from the event. The reporter assessed the case as non-serious.
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 724334), concerns a 56-year-old, adult, female patient. The patient's current condition included asthma (reported as medical history) (since an unspecified date). On 14-Oct-2017, the patient was administered FLUVIRIN Thiomersal (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 1720701 and expiry date: not reported). On the same day after vaccination, the patient experienced pain and swelling in arm. The patient visited the emergency room and received antibiotics (unspecified). At the time of this report, the outcome of the events was unknown. The reporter assessed this case as non-serious. Update 31-Jul-2018: Non-significant case correction performed 10-Jul-2018: In the case comment suspect vaccine 'FLUVIRIN Thiomersal' was mentioned.
Age: 59.0
Sex: M
Vaccine: FLU3
Symptoms: Pyrexia, Skin warm
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 724341), concerns a 59-year-old, adult, male patient. The patient's current condition included high blood pressure (since an unspecified date) (reported as medical history). On 19-Oct-2017, approximately at 11:03 hours, the patient was administered FLUVIRIN (dose: 0.5 ml [reported as 1st dose], anatomical location: left arm, batch number: [reported as 1799C3O] and route of administration: unknown and expiry date: not reported). Seqirus quality Assurance have confirmed that the batch number reported (1799C3O) is not a valid batch number however, because the reporter named Seqirus product 'FLUVIRIN' as the suspect vaccine, this report has been conservatively entered as a Seqirus case. On the same day, approximately at 11:35 hours after vaccination, the patient returned to emergency room with complaint of fever and was slightly hot to touch. The patient's blood pressure (BP) was found to be 152/89 and later it was 132/88. The patient's color was normal, gait was fine and dizziness, rash and breathing issues were not observed. It was reported that, the patient walked along highway on own without any assistance. At the time of this report, the patient had recovered from the events. The reporter assessed the case as non-serious. Update 17-Jul-2018: Significant case correction was performed with IRD 10-Jul-2018: Seqirus Quality Assurance have confirmed that the batch number reported (1799C3O) is not a valid batch number however, because the reporter named Seqirus product 'FLUVIRIN' as the suspect vaccine, this report has been conservatively entered as a Seqirus case.
Age: 63.0
Sex: M
Vaccine: FLU3
Symptoms: Pruritus, Rash
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 724369), concerns a 63-year-old, adult male patient. On 12-Oct-2017, the patient was administered FLUVIRIN Thiomersal (dose: 0.5 ml (reported as 1st dose), route of administration: intramuscular, batch number: 1720801, anatomical location: unknown, expiry date: not reported). On the following day (13-Oct-2017), the patient developed bumps on wrists, elbows, neck and was itching. It was reported that, bumps were not spreading and had no pain. At the time of this report, the outcome of the event was unknown. The reporter assessed this case as non-serious.
Age: 37.0
Sex: F
Vaccine: FLU3
Symptoms: Dyspnoea, Vasodilatation, Wheezing
Clinical narrative: This is a spontaneous case, reported by other health professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 724789), concerns a 37-year-old, adult female patient. The patient was allergic to penicillin, vancomycin, tramadol and KEFLEX. The patient's concomitant medications were unknown. On 30-Oct-2017, the patient was administered FLUVIRIN (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 170104P and expiry date: not reported). On the same day, after vaccination, the patient experienced shortness of breath, wheezing and visible distended blood vessels in neck. The patient had an emergency room and office visit. It was unknown, whether any lab investigations performed. At the time of this report, the outcome of the events (shortness of breath, wheezing, visible distended blood vessels in neck) was unknown. The reporter assessed the case as non-serious.
Age: 25.0
Sex: F
Vaccine: FLU3
Symptoms: Burning sensation, Fatigue, Flushing, Hyperhidrosis, Tremor
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 724842) concerning a 25-year-old, adult, female patient. On 25-Oct-2017, the patient was administered FLUVIRIN (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179904P [reported as 179904D] and expiry date: not reported). On the same day, approximately 20 minutes after vaccination, the patient experienced flushing, sweating, burning sensation, trembling and vomiting (reported as throwing up). On 26-Oct-2017 (reported as next day), the patient was very tired. At the time of this report, the patient had recovered from the events. The reporter considered the case as non-serious. Update on 14-Aug-2018: Non-significant case correction was performed with IRD 10-Jul-2018: The sentence 'after vaccination with FLUVIRIN and tiredness one day after vaccination with FLUVIRIN was modified to 'on the same day of vaccination and tiredness on the next day after receipt of FLUVIRIN vaccine' in the case comment.
Age: 25.0
Sex: F
Vaccine: FLU3
Symptoms: Vomiting
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 724842) concerning a 25-year-old, adult, female patient. On 25-Oct-2017, the patient was administered FLUVIRIN (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179904P [reported as 179904D] and expiry date: not reported). On the same day, approximately 20 minutes after vaccination, the patient experienced flushing, sweating, burning sensation, trembling and vomiting (reported as throwing up). On 26-Oct-2017 (reported as next day), the patient was very tired. At the time of this report, the patient had recovered from the events. The reporter considered the case as non-serious. Update on 14-Aug-2018: Non-significant case correction was performed with IRD 10-Jul-2018: The sentence 'after vaccination with FLUVIRIN and tiredness one day after vaccination with FLUVIRIN was modified to 'on the same day of vaccination and tiredness on the next day after receipt of FLUVIRIN vaccine' in the case comment.
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Immediate post-injection reaction, Mass
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 724844), concerns a 48-year-old, adult female patient. The patient's current condition included asthma (reported as medical history) (since an unspecified date). On 27-Oct-2017, the patient was administered FLUVIRIN (dose: 0.5 ml (reported as 1st dose), route of administration: intramuscular, batch number: 179904P, anatomical location: left arm and expiry date: not reported). On the same day, immediately after vaccination, the patient developed white round lump under her arm. At the time of this report, the patient had recovered from the events. The reporter assessed the case as non-serious.
Sex: M
Vaccine: FLU3
Symptoms: Injection site bruising, Injection site discolouration, Injection site pain
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 724967), concerns a 48-year-old, adult, male patient. On 24-Oct-2017, the patient was administered FLUVIRIN (dose: 0.5 ml, frequency reported as 1, batch number: 170104P, route of administration: injection [SYR as reported], anatomical location: left arm). On 25-Oct-2017, within 24 hours after vaccination, the patient experienced injection site bruise approximately 1-2 inch in diameter which persisted for 10 days (until the day of presentation). Initially, bruise appeared dark blue/black, but turned [as reported resolving] into brown/green/yellow at the time of presentation, accompanied by mild pain upon contact. On 03-Nov-2017, the patient presented to the pharmacy with the reported events. It was stated that, the patient was told to return to pharmacy or contact physician if bruising failed to resolve. The outcome of the events (mild pain and bruise approximately 1-2 inches in diameter at the injection site/bruising was initially dark blue/black) was unknown. The reporter assessed this case as non-serious. Update on 31-Jul-2018: Non-significant case correction was performed with IRD 10-Jul-2018: Latency period and suspect vaccine was mentioned in the case comment. Update on 23-Aug-2018: Non-significant case correction was performed with IRD 10-Jul-2018: The repeated word 'after vaccination' was deleted from the case comment.
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725237), concerning a 52-year-old, adult female patient. The patient had no medical history and current illness. On 01-Nov-2017, the patient was administered with FLUVIRIN (dose: 0.5 ml (reported as 1 dose), batch number: 179802P, anatomical location: left arm, route of administration and expiry date: not reported). On 02-Nov-2017, after 1 day of vaccination, the patient developed swelling, redness and hot spot on the arm. The patient was advised to put ice on it and take ibuprofen. At the time of this report, the outcome of the events was unknown. The reporter assessed the event as non-serious.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Blood test, Chest discomfort, Diarrhoea, Electrocardiogram, Fatigue
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 725278), concerns a 65-year-old, elderly, female patient. The patient's historical condition included: mediastinum mass. Current illness included: irritable bowel syndrome (IBS) and high blood pressure (reported as medical history). The patient was allergic to penicillin and some fish. Concomitant medications included: PROZAC, NORVASC, baby aspirin, Vitamin D3 and Colestipol for an unknown indication. On 20-Oct-2017, approximately at 04:30 pm, the patient was administered FLUVIRIN (dose: 0.5 ml, route of administration: injection [reported as SYR], anatomical location: right arm, batch number, expiry date: not reported). On 20-Oct-2017 by 06:30 pm (approximately after 2 hrs) after vaccination, the patient became extremely sick, felt exhausted, had diarrhea, and sick feeling radiating through the whole body (throughout the night). On 21-Oct-2017 (Saturday), the patient called the physician who instructed to take TYLENOL and alternate with ADVIL. The patient received TYLENOL (reported as 2) and tried to do some housework. However, the patient got extremely exhausted, felt sick and had tightness in the chest. At 12:30, the patient again called the physician. The physician instructed the patient to visit emergency room. On the same day (21-Oct-2017), in the emergency room, repeated electrocardiography and blood work up was done but the results were not reported. By 5:00 pm, the patient started to get some relief from the symptoms. The patient laid low with illness on Sunday and Monday (as reported) and on Tuesday, she went to work. At the time of this report, the patient had recovered from all the events. The reporter assessed this case as non-serious. Update on 31-Jul-2018: Case correction was performed with IRD 10-Jul-2018: The treatment received for the event 'chest tightness' was changed from 'yes" to "no" in the event tab.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Malaise
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 725278), concerns a 65-year-old, elderly, female patient. The patient's historical condition included: mediastinum mass. Current illness included: irritable bowel syndrome (IBS) and high blood pressure (reported as medical history). The patient was allergic to penicillin and some fish. Concomitant medications included: PROZAC, NORVASC, baby aspirin, Vitamin D3 and Colestipol for an unknown indication. On 20-Oct-2017, approximately at 04:30 pm, the patient was administered FLUVIRIN (dose: 0.5 ml, route of administration: injection [reported as SYR], anatomical location: right arm, batch number, expiry date: not reported). On 20-Oct-2017 by 06:30 pm (approximately after 2 hrs) after vaccination, the patient became extremely sick, felt exhausted, had diarrhea, and sick feeling radiating through the whole body (throughout the night). On 21-Oct-2017 (Saturday), the patient called the physician who instructed to take TYLENOL and alternate with ADVIL. The patient received TYLENOL (reported as 2) and tried to do some housework. However, the patient got extremely exhausted, felt sick and had tightness in the chest. At 12:30, the patient again called the physician. The physician instructed the patient to visit emergency room. On the same day (21-Oct-2017), in the emergency room, repeated electrocardiography and blood work up was done but the results were not reported. By 5:00 pm, the patient started to get some relief from the symptoms. The patient laid low with illness on Sunday and Monday (as reported) and on Tuesday, she went to work. At the time of this report, the patient had recovered from all the events. The reporter assessed this case as non-serious. Update on 31-Jul-2018: Case correction was performed with IRD 10-Jul-2018: The treatment received for the event 'chest tightness' was changed from 'yes" to "no" in the event tab.
Age: 26.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Loss of personal independence in daily activities, Mobility decreased
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 725549), concerns a 26-year-old, adult, female patient. The patient had no relevant medical history. On 18-Oct-2017, the patient was administered FLUVIRIN (dose: 0.5 ml (reported as 1st dose), route of administration: intramuscular, anatomical location: left arm, batch number: 179901P, expiry date: not reported). On the same day, after vaccination, the patient experienced soreness at injection site for couple of days which affected movement leading to daily activities. The patient made a chiropractor visit for the events. The chiropractor stated that, the patient might have hit the bursa (reported as SIRVA). It was reported that, the patient's soreness at injection site had gradually subsided (recovered). At the time of this report, the outcome of the events mobility decreased and activities of daily living impaired was unknown. The reporter assessed the case as non-serious.
Age: 61.0
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Injection site bruising, Injection site erythema, Injection site pain, Nausea
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 725629), concerns a 61-year-old adult female patient. On 09-Oct-2017, the patient received FLUVIRIN [dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179705P and expiry date: not reported] and PREVNAR 13 (route of administration: intramuscular, anatomical location: left arm, batch number: S31255, dose and expiry date: not reported). On the same day after vaccination, the patient developed redness, soreness and bruising at the injection site. The patient also experienced nausea. The outcome of the events was unknown. The reporter assessed this case as non-serious.
Age: 22.0
Sex: F
Vaccine: FLU3, TDAP, VARCEL
Symptoms: Hot flush, Injection site erythema, Injection site swelling, Malaise, Nausea
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 725633), concerns a 22-year-old adult female patient. The patient's current illness included complete congenital heart block. On 27-Sep-2017, the patient received FLUVIRIN [dose: 0.5 ml, route of administration: unknown, anatomical location: unknown, batch number: 179604P (reported as 179604D) and expiry date: not reported], BOOSTRIX (dose: 2 as reported, route of administration: intramuscular, anatomical location: left arm, batch number: 72Z32 (as reported), and expiry date: not reported) and VARIVAX (dose: 1 as reported, route of administration: subcutaneous, anatomical location: right arm, batch number: N009768 (as reported) and expiry date: not reported). On 28-Sep-2017, the patient experienced hives on scalp, elbows and knees for 3 days, (Thursday, Friday and Saturday). On 29-Sep-2017, the patient developed hot flashes, redness around the injection site, body ache, ill feeling, nausea and bump at the injection site. At the time of this report, the patient had recovered from all the events (hot flush, injection site erythema, injection site swelling, malaise, nausea, pain and urticaria). The reporter assessed this case as non-serious.
Age: 22.0
Sex: F
Vaccine: FLU3, TDAP, VARCEL
Symptoms: Pain, Urticaria
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 725633), concerns a 22-year-old adult female patient. The patient's current illness included complete congenital heart block. On 27-Sep-2017, the patient received FLUVIRIN [dose: 0.5 ml, route of administration: unknown, anatomical location: unknown, batch number: 179604P (reported as 179604D) and expiry date: not reported], BOOSTRIX (dose: 2 as reported, route of administration: intramuscular, anatomical location: left arm, batch number: 72Z32 (as reported), and expiry date: not reported) and VARIVAX (dose: 1 as reported, route of administration: subcutaneous, anatomical location: right arm, batch number: N009768 (as reported) and expiry date: not reported). On 28-Sep-2017, the patient experienced hives on scalp, elbows and knees for 3 days, (Thursday, Friday and Saturday). On 29-Sep-2017, the patient developed hot flashes, redness around the injection site, body ache, ill feeling, nausea and bump at the injection site. At the time of this report, the patient had recovered from all the events (hot flush, injection site erythema, injection site swelling, malaise, nausea, pain and urticaria). The reporter assessed this case as non-serious.
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Feeling hot, Paraesthesia, Vomiting
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 725634), concerns a 34-year-old, adult, female patient. The patient's current illness included: asthma (reported as medical history). On 26-Oct-2017, at 10:15 am, the patient was administered FLUVIRIN (dose: 0.5 ml (reported as first dose), anatomical location: left arm, batch number: 179801P [reported as 179801D], route of administration: unknown, expiry date: not reported). On the same day (26-Oct-2017) after vaccination, the patient started feeling hot and tingly a 10:30 am. At 11:30 am, took BENADRYL and went to check in  with the reporter. At 11:45 am, the patient was made to sit and asked to take BENADRYL again. The patient stated that, she was feeling better. Later, the patient went to bathroom and she threw up at 11:55 am. At 12:10 am, the patient used VENTOLIN inhaler. The patient had no breathing problems. However, the patient had chest tightness. The reporter awaited call back from the physician, but the patient stated to the reporter that, she felt better. However, the patient's husband picked her up and was going to the physician. At the time of this report, the patient had not recovered from the events. The reporter assessed this case as non-serious. Update 19-Jul-2018: Significant case correction received with IRD 10-Jul-2018: The batch number (179801P) was captured in the field and in the narrative.
Sex: F
Vaccine: FLU3
Symptoms: Fluid retention, Joint swelling, Peripheral swelling
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 725770), concerns a 60-year-old, adult, female patient. The patient's historical condition included: asthma. On 04-Nov-2017, the patient was administered FLUVIRIN (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179601P, expiry date: not reported). On an unspecified date in Nov-2017, about 6 hours after vaccination, the patient experienced swelling or water retaining in hands and ankles. The patient took LASIX and swelling had resolved on Wednesday morning. At the time of this report, the outcome of the events was not reported. The reporter assessed this case as non-serious.
Age: 54.0
Sex: F
Vaccine: FLU3, PPV, TDAP
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 725880), concerns a 54-year-old, adult female patient. On 27-Oct-2017, the patient was administered FLUVIRIN (dose: 0.5 ml [unknown as reported], route of administration: intramuscular, anatomical site: left arm, batch number: 179802P). On the same day, the patient also received non-company suspect PNEUMOVAX (frequency : 2, dose, route of administration: intramuscular, anatomical site: left arm, batch number: N022703) and ADACEL (dose: unknown, route of administration: intramuscular, anatomical site: right arm, batch number: U5702AA). On 28-Oct-2017, one day after vaccination, the patient developed swollen arm which was red and hot to the touch. It was reported that, swelling began to resolve [reported as started going away] after 4 days. On an unspecified date, the patient had an office visit and emergency room visit. At the time of this report, the event swollen arm was resolving, while the outcome of the events red and hot to the touch was unknown. The reporter assessed this case as non-serious. Update 24-Aug-2018: Non-significant case correction was performed with IRD 10-Jul-2018: Case comment was modified from 'plausible temporal relationship' to 'plausible temporal relationship between vaccination to event onset and localized events of the injected limb'.
Age: 62.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 725885), concerns a 62-year-old, adult female patient On 30-Oct-2017, the patient was administered FLUVIRIN [dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179802P and expiry date: not reported]. On the same day, the patient also received non-company suspect vaccine PNEUMOVAX [dose: unknown, route of administration: intramuscular, anatomical location: left arm, batch number: N022703 and expiry date: not reported]. On 31-Oct-2017, 1 day after vaccination, the patient's arm was swollen, red and hot to the touch. The patient made an emergency room or office visit. It was reported that, swelling started to go away after 4 days (recovering). The outcome of the events (red and hot to the touch) was not reported. The reporter assessed this case as non-serious. Update on 31-Jul-2018: Non-significant case correction was performed with IRD 10-Jul-2018: The sentence 'due to the anatomical location of the event' was deleted from the case comment. Update 05-Sep-2018: Non-significant case correction was performed with IRD 10-Jul-2018: The patient's age at vaccination (62 years) was added in patient tab. No changes were done in the narrative.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Musculoskeletal pain
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 725922), concerns a 57-year-old, adult, female patient. The patient had no relevant medical history, current illnesses and allergies. The patient's concomitant medications included SYNTHROID, Estrogen, medroxyprogesterone, B-12. On 18-Oct-2017, the patient was administered FLUVIRIN (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm). On 19-Oct-2017, the patient experienced severe pain in left shoulder, in the deltoid region while raising above head (as reported). The patient had not yet recovered from the event 'injection site pain'. The reporter assessed this case as non-serious.
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site discomfort, Injection site erythema, Injection site swelling
Clinical narrative: This is a spontaneous case, reported by other health professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 726164), concerns a 61-year-old, adult, female patient. The patient did not use any concomitant medications at the time of vaccination. On 08-Nov-2017, the patient was administered FLUVIRIN Thiomersal (dose: 0.5 ml [frequency reported as 1], batch number: 1720701, route of administration: intramuscular, anatomical location: left arm). On the same day, after vaccination, the patient experienced redness, soreness and swelling at injection site. The patient visited the emergency department and treated with unspecified medications. At the time of this report, the patient had not yet recovered from the events. The reporter assessed this case as non-serious. Update 31-Jul-2018: Non-significant case correction performed 10-Jul-2018: In the case comment, 'due to the anatomical location of the events' was removed.
Age: 40.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect route of product administration, Pruritus, Rash erythematous
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 726169), concerns a 40-year-old, adult, female patient. The patient had no medical history and current illnesses, however, the patient's concomitant medications included oral contraceptives (unspecified), daily vitamin for unknown indications. On 07-Nov-2017, the patient was administered FLUVIRIN (dose: 0.5ml [frequency reported as 1], route of administration: intradermal, anatomical location: left arm, batch number: 179602P). On 08-Nov-2017, the patient experienced, a confluent itch and erythematous rash which spread to trunk, arms and legs intermittently for 2 days. The patient had not recovered from the events (confluent itch and erythematous rash which spread to trunk, arms and legs). The reporter assessed this case as non-serious. Update received on 28-Sep-2018: Non-significant case correction done with IRD 10-Jul-2018: Added 'age at vaccination' as 40 years and sentence in the event section of narrative was reframed. Case comment changed accordingly.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Acupuncture, Injection site pain, Musculoskeletal pain, Neck pain
Clinical narrative: This is a spontaneous case, reported by other health professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 726284), concerns a 55-year-old, adult, female patient. The patient's current conditions included high blood pressure, allergy to vitamin B, ginseng, egg white and yeast (reported as medical history) (since an unspecified date). The patient's concomitant medication included unspecified medications for high blood pressure, Omega 3 and Acai berries. On 05-Oct-2017, the patient was administered FLUVIRIN (dose: 0.5 ml [frequency reported as 1], batch number: 179605P, route of administration: intramuscular, anatomical location: left arm and expiry date: not reported). On the same day after vaccination, the patient experienced injection site pain and pain spread to her shoulder and neck area due to which she missed her work for 3 days. The patient tried over the counter (OTC) muscle rubs and consulted an acupuncturist. At the time of this report, the patient had not yet recovered from the events. The reporter assessed this case as non-serious. Update 31-Jul-2018: Non-significant case correction received 10-Jul-2018: The suspect product information was added in the case comment. No changes were done in the narrative.
Age: 31.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site warmth, Peripheral swelling
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 726347), concerns a 31-year-old, adult, female patient. On 22-Oct-2017, the patient was administered with FLUVIRIN (dose: 0.5 ml [reported as 1st dose], route of administration: intramuscular, batch number: 179804P, anatomical location and expiry date: not reported) and non-company suspect product PNEUMOVAX (dose: reported as 1st dose, route of administration: intramuscular, batch number: M041394, anatomical location and expiry date: not reported). On 23-Oct-2017, after one day of vaccination, the patient's injection site was warm and red to touch. Furthermore, the patient also experienced swollen arm. Subsequently, the patient went to the emergency room. At the time of this report, the patient had recovered from the events. The reporter assessed the case as non-serious.
Age: 63.0
Sex: F
Vaccine: FLU3
Symptoms: Peripheral swelling
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 726356), concerns a 63-year-old, adult, female patient. On 11-Nov-2017, the patient was administered FLUVIRIN (dose: 0.5 ml [reported as first dose], route of administration: intramuscular, anatomical location: left arm, batch number: 179805P, and expiry date: not reported). On the same day, 1 hour after vaccination, the patient experienced swelling in the left hand which continued to increase and decreased overnight. On 12-Nov-2017, the patient reported to pharmacy and was recommended for a doctor visit. At the time of this report, the patient had not recovered from the event. The reporter assessed the case as non-serious.
Age: 38.0
Sex: F
Vaccine: FLU3
Symptoms: Contusion
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 726405), concerns a 38-year-old, adult, female patient. The patient had no medical history. However, the patient's concomitant medication included RITALIN for an unknown indication. On 29-Oct-2017, the patient was administered with FLUVIRIN Thiomersal (dose: 0.5 ml, route of administration: intramuscular, batch number: 1721501, anatomical location and expiry date: not reported). On the same day, after vaccination, the patient developed half dollar sized bruise (unspecified location). No lab investigations were performed. At the time of this report, the patient had not yet recovered from the event. The reporter assessed the case as non-serious.
Age: 71.0
Sex: M
Vaccine: FLUX, PPV
Symptoms: Erythema, Pain in extremity, Peripheral swelling
Clinical narrative: This spontaneous case, reported by a pharmacist to VAERS and initially retrieved on 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 729500), concerns a 71-year-old, elderly, male patient. The patient's current conditions included, high blood pressure, high cholesterol and diabetes (reported as medical history). The patient's concomitant medications and allergies were not reported. On 11-Apr-2017 (at 12:00 pm), the patient was administered influenza vaccine (dose: unknown, route of administration: injection (reported as SYR), anatomical location: left arm, batch number, expiry date, trade name, manufacturer: not reported). On the same day (at 10:00 am), the patient was also administered with PNEUMOVAX (dose, route of administration: intramuscular, anatomical location: left arm, batch number: N022703, expiry date: not reported). On an unspecified date in 2017, after vaccination, the patient experienced swelling of left arm, redness and pain (between the shoulder and elbow of the arm). The outcome of the events was unknown. The reporter assessed this case as non-serious. Update 11-Jul-2018: Non-significant case correction was performed 06-Jun-2018: A phrase in case comment was changed from 'vaccination' to 'vaccination with INN flu vaccine'. No changes were made in narrative.
Sex: M
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 726565), concerns a 50-year-old, adult, male patient. On 03-Oct-2017, the patient was administered FLUVIRIN (dose: 0.5 ml, route of administration: intramuscular, batch number: 179701P, anatomical location and expiry date: not reported). On 05-Oct-2017, 2 days after vaccination, the patient felt pain at the injection site. It was reported that the pain had not gone away. The patient was recommended to consult his physician as soon as possible. At the time of this report, the patient had not recovered from the event (injection site pain). The reporter assessed the case as non-serious. Update on 31-Jul-2018: Non-significant case correction was performed with IRD 10-Jul-2018: The sentence 'pain was not gone' was corrected to 'pain had not gone' in the narrative.
Age: 72.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Chills, Impaired work ability, Limb discomfort, Pyrexia, Sleep disorder
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 726700), concerns a 72-year-old elderly male patient. On 24-Oct-2017, the patient was administered FLUVIRIN Thiomersal (dose: 0.5 ml, route of administration: intramuscular, batch number: 1720901, anatomical location: left arm and expiry date: not reported) and non-company suspect product PNEUMOVAX (route of administration: intramuscular, batch number: N014946, anatomical location: left arm, dose and expiry date: not reported). On the same day, after vaccination, approximately at 6:00 pm, the patient experienced extreme soreness in left arm, fever, chills and was unable to sleep throughout the night. On 25-Oct-2017 (reported as next morning), the patient felt better, but still did not feel well enough to go to work. It was reported that, patient felt better throughout the day. At the time of this report, the patient had recovered from the events. The reporter assessed the case as non-serious.
Age: 65.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Cold sweat, Erythema, Injection site urticaria, Limb discomfort, Pruritus
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 726704), concerns a 65-year-old, elderly, female patient. On 24-Oct-2017, the patient was administered FLUVIRIN Thiomersal (dose: 0.5 ml, route of administration: intramuscular, batch number: 1720901, anatomical location: left arm and expiry date: not reported) and non-company suspect product PNEUMOVAX (route of administration: intramuscular, batch number: N014946, anatomical location: left arm, dose and expiry date: not reported). On the same day, after vaccination, the patient experienced very sore arm, hives around injection site, cold sweat, which lasted the next morning (as reported). The patient also experienced redness, itchiness and rash on the left arm, which were continued for approximately 4 days. At the time of this report, the outcome of the events was not reported. The reporter assessed this case as non-serious. Update 31-Jul-2018: Case correction was performed with IRD 10-Jul-2018: The sentence in the case comment was corrected from 'the company is assessed the causality of the events as related to the suspect vaccine due to injection site-specific reaction and plausible temporal relationship. The causal role of the suspect vaccine cannot be ruled out. However, PNEUMOVAX was considered as co-suspect vaccine' to 'the company assessed the causality of all the events as related to the suspect vaccine due to plausible temporal relationship between vaccination and reported events'.
Age: 65.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Rash
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 726704), concerns a 65-year-old, elderly, female patient. On 24-Oct-2017, the patient was administered FLUVIRIN Thiomersal (dose: 0.5 ml, route of administration: intramuscular, batch number: 1720901, anatomical location: left arm and expiry date: not reported) and non-company suspect product PNEUMOVAX (route of administration: intramuscular, batch number: N014946, anatomical location: left arm, dose and expiry date: not reported). On the same day, after vaccination, the patient experienced very sore arm, hives around injection site, cold sweat, which lasted the next morning (as reported). The patient also experienced redness, itchiness and rash on the left arm, which were continued for approximately 4 days. At the time of this report, the outcome of the events was not reported. The reporter assessed this case as non-serious. Update 31-Jul-2018: Case correction was performed with IRD 10-Jul-2018: The sentence in the case comment was corrected from 'the company is assessed the causality of the events as related to the suspect vaccine due to injection site-specific reaction and plausible temporal relationship. The causal role of the suspect vaccine cannot be ruled out. However, PNEUMOVAX was considered as co-suspect vaccine' to 'the company assessed the causality of all the events as related to the suspect vaccine due to plausible temporal relationship between vaccination and reported events'.
Age: 17.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site hypoaesthesia, Injection site pain, Paraesthesia
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 726714), concerns a 17-year-old, adolescent female patient. The patient was allergic to penicillin and Cefdinir. The patient had no current illness. On 14-Nov-2017, the patient was administered FLUVIRIN (dose: 0.5 ml [frequency reported as first dose], route of administration: intramuscular, anatomical location: left arm, batch number: 179904P and expiry date: not reported). On the same day after vaccination, the patient experienced injection site pain and numbness from injection site to fingers. The patient also experienced tingling in fingers. It was reported that, all the reactions occurred in the vaccinated arm. At the time of this report, the outcome of the events was unknown. The reporter assessed this case as non-serious. Update 31-Jul-2018: Non-significant case correction was performed with IRD 10-Jul-2018: The case comment was corrected. No changed were done in the narrative.
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Vaccination site pain, Vaccination site swelling
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 10-Jul-2018 by Seqirus from VAERS (VAERS ID: 726802), concerns a 38-year-old, adult, female patient. The patient's medical history was not reported and had no current illness. On 24-Oct-2017, the patient was administered FLUVIRIN (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 170104P, expiry date: not reported). At the time of shot and following two days, the patient had stinging at the site of vaccination. On 26-Oct-2017, 2 days after vaccination, the patient had swelling and pain in that area (vaccination site). As of 14-Nov-2017, the patient had pain and swelling (not recovered). The patient could not see redness around the site. The patient was advised to receive medical attention. The reporter assessed the case as non-serious. Update 31-Jul-2018: Non-significant case correction was performed with IRD 10-Jul-2018: Added 'plausible temporal relationship' as reason for assessing the causality as related for the events. Case comment was amended. No changes were made in the narrative.